Immune mediated 'HAART' attack during treatment for tuberculosis

International Journal of Tuberculosis and Lung Disease

Volumn 3, Issue 10, 1999, Pages 944-947

  Kunimoto, D Y ^a,b   Chui, L ^a   Nobert, E ^a   Houston, S ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

^b UNIVERSITY OF ALBERTA HOSPITAL   (Canada)

Author keywords

Anti HIV agents; Drug therapy; HIV; Tuberculosis

Indexed keywords

ANTIRETROVIRUS AGENT; CD4 ANTIGEN; CORTICOSTEROID; COTRIMOXAZOLE; GANCICLOVIR; ISONIAZID; LAMIVUDINE; METHYLPREDNISOLONE; PYRAZINAMIDE; RIFABUTIN; RIFAMPICIN; STAVUDINE; TUBERCULOSTATIC AGENT;

ACUTE RESPIRATORY FAILURE; ADULT; ARTICLE; BRONCHOSCOPY; CASE REPORT; COUGHING; GRANULOMATOUS INFLAMMATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; IMMUNOLOGICAL MONITORING; INTRAVENOUS DRUG ADMINISTRATION; LUNG TUBERCULOSIS; MALE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; OPEN LUNG BIOPSY; PNEUMOCYSTIS CARINII; PNEUMOCYSTIS PNEUMONIA; PRIORITY JOURNAL; VIRUS INHIBITION; WEIGHT REDUCTION; X RAY;

ACUTE DISEASE; ADRENAL CORTEX HORMONES; ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTI-HIV AGENTS; ANTITUBERCULAR AGENTS; CANADA; DRUG THERAPY, COMBINATION; HIV-1; HUMANS; MALE; RESPIRATORY INSUFFICIENCY; TUBERCULOSIS, PULMONARY; VIETNAM;

EID: 0032876666     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Lienhardt C, Rodrigues L C. Estimation of the impact of the human immunodeficiency virus infection on tuberculosis: tuberculosis risks re-visited? Int J Tuberc Lung Dis 1997; 1: 196-204.
2. Telenti A, Marchesi F, Balz, M, Bally F, Böttger E C, Bodmer T. Rapid identification of mycobacteria to the species level by polymerase chain reaction and restriction enzyme analysis. J Clin Microbiol 1993; 31: 175-178.
3. Mouton Y, Alfandari S, Valette M, et al. Impact of protease inhibitors on AIDS-defining events and hospitalizations in 10 French AIDS reference centres. AIDS 1997; 11: F101-F105.
4. Hadad D J, Lewi D S, Pignatari A C, Martins M C, Vitti Junior W, Arbeit R D. Resolution of Mycobacterium avium complex bacteremia following highly active antiretroviral therapy. Clin Infect Dis 1998; 26: 758-759.
5. Gerna G, d'Arminio Monforte A, Zavattoni M, et al. Sharp drop in the prevalence of human cytomegalovirus leuko-DNAemia in HIV-infected patients following highly active antiretroviral therapy. AIDS 1998; 12: 118-120.
6. Race E M, Adelson-Mitty J, Kriegel G R, et al. Focal mycobacterial lymphadenitis following initiation of protease-mhibitor therapy in patients with advanced HIV-1 disease. Lancet 1998; 351: 252-255.
7. Jacobson M A, Zegans M, Pavan P R, et al. Cytomegalovirus retinitis after initiation of highly active antiretroviral therapy. Lancet 1997; 349: 1443-1445.
8. Rodriguez-Bano J, Muniain M A, Aznar J, Perez-Cano R, Corral J L. Systemic paradoxical response to antituberculosis drugs: resolution with corticosteroid therapy. Clin Infect Dis 1997; 24: 517-519.
9. Afghani B, Lieberman J M. Paradoxical enlargement or development of intracranial tuberculomas during therapy: case report and review. Clin Infect Dis 1994; 19: 1092-1099.
10. Onwubalili J K, Scott G M, Smith H. Acute respiratory distress related to chemotherapy of advanced pulmonary tuberculosis: a study of two cases and review of the literature. Q J Med 1986; 59: 599-610.
11. Chien J W, Johnson J L. Paradoxical reactions in HIV and pulmonary TB. Chest 1998; 114: 933-936.
12. Narita M, Ashkin D, Hollender E S, Pitchenik A E. Paradoxical worsening of tuberculosis following antiretroviral therapy in patients with AIDS. Am J Respir Crit Care Med 1998; 158: 157-161.